Newspatrolling.com News cum Content Syndication Portal Online
Hyderabad, 31st March 2025: HRV Global Life Sciences, India’s first virtual integrated pharmaceutical company, proudly announces the successful delivery of the first shipment of anti-diabetic medications to Mendoza, Argentina. The consignment of USFDA qualified Metformin (1000mg) was received by the province of Mendoza for distribution in the public health system. This historic moment marks a significant step in strengthening relationship between India and Argentina, aiming to provide affordable healthcare solutions to thousands of Argentine patients.
This milestone was made possible through the visionary leadership of Mendoza’s Governor Alfredo Cornejo and India’s Ambassador to Argentina, Dinesh Bhatia. The structural changes in policy brought by President Javier Milei, the Minister of Health Mario Lugones and Minister of Deregulation Federico Sturzenegger, gave a boost to this ground breaking undertaking. As a first time ever in the history of Argentina, Province of Mendoza invested $150,000 in this initiative, achieving estimated savings of 45-50% compared to regular prices, underscoring India’s role in the global supply chain in addressing their healthcare challenges.
“This landmark shipment represents more than just a business collaboration—it is a testament to our commitment to making affordable healthcare accessible to all. We are proud to support Argentina’s healthcare system and strengthen the bond between our two nations. As Rodolfo Montero, Mendoza’s Minister of Health, described, this delivery truly marks a historic achievement for both Argentina and India,” said Mr. Hari Kiran Chereddi, Managing Director of HRV Global Life Sciences.
HRV Global Life Sciences remains committed to deepening its partnership with Argentina and providing life-saving medications to Latin America. The scope of this initiative is being extended to more provinces of Argentina and additional therapeutic segments including Oncology and Cardiology. These medications were manufactured in HRV’s CDMO partner site and serves as the validation of HRV’s virtual pharma model for the first time in India for both API and FDF. This initiative represents the first of many, reaffirming HRV Global Life Sciences’ vision for a healthier, more accessible future.
